Heramed (ASX:HMD) - Insights
ASX:HMD · Data intelligence from 13 published articles
Total Articles
13
all time
Materiality Rate
96%
of announcements
Signal Strength
Moderate
avg newsworthiness
Positive Tone
69%
of published articles
Publication Activity
Signal Strength Trend
Tone Split
Announcement Types
Impact Profile
Publication Heatmap Sydney time · day × hour
0h6h12h18h
Sun
Mon
Tue
Wed
Thu
Fri
Sat
Less
More
Announcement Signals
How often each theme appears across all enriched announcements for this company.
Capital Impact
High
44% of announcements reference capital raises, buybacks, or funding changes
Legal & Compliance
High
63% of announcements mention regulatory, legal, or compliance matters
Board Changes
Moderate
26% of announcements involve executive or board-level appointments
Price Guidance
None
No price guidance issued in announcements
Major Contracts
Moderate
37% of announcements reference significant contract wins or losses
Environmental
None
No environmental disclosures detected
IP & Patents
Low
11% of announcements mention intellectual property or patent activity
Research & Data
Moderate
37% of announcements contain research results or clinical/trial data